Aromatherapy With Lavender as Anxiolysis Prior to Cataracts Surgery

Withdrawn before enrolling · Not applicable

Conditions studied: Aromatherapy, Anxiety

In brief

The purpose of this study is to assess the validity of lavender aromatherapy as a method of anxiolysis prior to a cataract surgery, and to see if this effect will extend intraoperatively to minimize patients' intraoperative medication requirements. The study team plans on enrolling 186 participants. The investigator team hypothesizes that: 1. Participants will have a lower anxiety score after the intervention 2. Participants will require less intraoperative sedation medication compared to participants that did not have the lavender intervention. 3. A decrease in intraoperative medication requirements will lead to a faster discharge time

Key facts

Study ID

NCT05708066

Run by

Montefiore Medical Center

People needed

0

Starts

2024-01-01

Expected to finish

2024-10-01

Last updated by the study team

2024-02-08

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Over the age of 18
• ASA (American Society of Anesthesiology) score <=3
• Patients must be able to consent to participating in the study

You may not qualify if…

• ASA score >4
• Patients with a psychiatric diagnosis or who are on psychiatric medication
• Patients with a history of asthma
• Patients with an allergy to lavender
• Patients under an anesthetic plan that has been switched from local anesthesia with sedation to general anesthesia
• VAS score > 60 pre-operatively (high anxiety score)

Where it is running

• Montefiore Medical Center Hutchinson Campus — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.